OSSD Share Price Performance
SEK 14.40
6.53 (82.97%)
7.1% undervalued intrinsic discount
SEK 15.50
Fair Value
Price SEK 14.40
AnalystConsensusTarget SEK 15.50
Fair ValueSEK 15.50
Share PriceSEK 14.40
7.1% undervalued intrinsic discount
OSSD Community Narratives
AN
Fair Value SEK 15.50 7.1% undervalued intrinsic discount
Pure Play Orthobiologics Will Expand US Healthcare Access
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
Recent OSSD News & Updates
OssDsign AB (publ) Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Nov 04, 2025
- Earnings per share (EPS)
- -0.48
- Gross Margin
- 95.98%
- Net Profit Margin
- -35.06%
- Debt/Equity Ratio
- 0.04%
OssDsign AB (publ) Competitors
Snowflake Analysis
About OSSD
- Founded
- 2011
- Employees
- 32
- CEO
- WebsiteView website
OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. It offers OssDsign Catalyst, a nanosynthetic bone graft for dual bone formation pathways through fusion mass. The company was founded in 2011 and is headquartered in Uppsala, Sweden.
Market Insight
Market sentiment on BTC treasury companies is moving, and with volatility rising, disagreements over their future prospects are as heated as ever.
Continue reading
Swedish Market Performance
- 7 Days: 0.7%
- 3 Months: 4.9%
- 1 Year: -0.07%
- Year to Date: 1.8%
The Energy sector gained 61% while the market remained flat over the last week. Similarly, the market is flat for the past 12 months. As for the next few years, earnings are expected to grow by 17% per annum. Market details ›